Fundraising Fox
CryoTherapeutics
Founded 2009 · 25 employees on LinkedIn · 1 known investors
Find your way into CryoTherapeutics
Sign up to see every warm intro you have to CryoTherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CryoTherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CryoTherapeutics is developing a device-based treatment for vulnerable (high-risk) atherosclerotic plaque in the coronary arteries, a condition associated with coronary artery disease and heart attacks. The company targets a gap in cardiac care where existing options such as stents do not address the underlying plaque pathology.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does CryoTherapeutics do?
- CryoTherapeutics is developing a device-based treatment for vulnerable (high-risk) atherosclerotic plaque in the coronary arteries, a condition associated with coronary artery disease and heart attacks. The company targets a gap in cardiac care where existing options such as stents do not address the underlying plaque pathology.
- Who are CryoTherapeutics's investors?
- CryoTherapeutics's investors include Creathor Ventures.